Harvard University has decided to retain the Sackler name on two of its buildings, despite protests from anti-opioid organizations and families affected by the opioid crisis. The decision stands in contrast to numerous institutions globally that have removed the Sackler name due to its association with Purdue Pharma, the company behind OxyContin, a drug linked to the opioid epidemic. The Harvard Corporation's decision was based on a report that questioned Arthur Sackler's involvement in the opioid crisis, citing his death nine years before OxyContin's release. The report also noted that Sackler's marketing techniques might not have been applied to OxyContin if he knew of its addictive potential. This decision has sparked outrage among advocates for the name change, who argue that Harvard's association with the Sackler name is an affront to victims of overdose and their families.
This content was created in partnership and with the help of Artificial Intelligence AI
